Table of Content




1. Executive Summary


2. Global Epigenetic Drug and Diagnostic Technology Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Epigenetic Drug and Diagnostic Technology Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Epigenetic Drug and Diagnostic Technology Market by Type of Therapy
3.3.1: HDAC
3.3.2: DNMT

3.4: Global Epigenetic Drug and Diagnostic Technology Market by Technology
3.4.1: DNA Methylation
3.4.2: Histone Methylation
3.4.3: Histone Acetylation
3.4.4: Large Noncoding RNA
3.4.5: Microrna Modification
3.4.6: Chromatin Structures

3.5: Global Epigenetic Drug and Diagnostic Technology Market by Application
3.5.1: Oncology
3.5.2: Non-oncology





4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Epigenetic Drug and Diagnostic Technology Market by Region
4.2: North American Epigenetic Drug and Diagnostic Technology Market
4.2.2: North American Epigenetic Drug and Diagnostic Technology Market by Application: Oncology and Non-oncology


4.3: European Epigenetic Drug and Diagnostic Technology Market
4.3.1: European Epigenetic Drug and Diagnostic Technology Market by Type of Therapy: HDAC and DNMT
4.3.2: European Epigenetic Drug and Diagnostic Technology Market by Application: Oncology and Non-oncology


4.4: APAC Epigenetic Drug and Diagnostic Technology Market
4.4.1: APAC Epigenetic Drug and Diagnostic Technology Market by Type of Therapy: HDAC and DNMT
4.4.2: APAC Epigenetic Drug and Diagnostic Technology Market by Application: Oncology and Non-oncology


4.5: ROW Epigenetic Drug and Diagnostic Technology Market
4.5.1: ROW Epigenetic Drug and Diagnostic Technology Market by Type of Therapy: HDAC and DNMT
4.5.2: ROW Epigenetic Drug and Diagnostic Technology Market by Application: Oncology and Non-oncology



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Epigenetic Drug and Diagnostic Technology Market by Type of Therapy
6.1.2: Growth Opportunities for the Global Epigenetic Drug and Diagnostic Technology Market by Technology
6.1.3: Growth Opportunities for the Global Epigenetic Drug and Diagnostic Technology Market by Application
6.1.4: Growth Opportunities for the Global Epigenetic Drug and Diagnostic Technology Market by Region

6.2: Emerging Trends in the Global Epigenetic Drug and Diagnostic Technology Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Epigenetic Drug and Diagnostic Technology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetic Drug and Diagnostic Technology Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Roche Diagnostics
7.2: Thermo Fisher Scientific
7.3: Eisai
7.4: Novartis
7.5: Illumina
7.6: Merck Sharp & Dohme
7.7: Qiagen